HIV-vaccine Research and Development in Thailand: Evolution and challenges
Thailand has been committed to HIV-Vaccine Research and Development since the launch of its National Plan, in 1993. Series of phase I/II trials, and two phase III clinical trials, have been conducted. The first efficacy trial was conducted with a high-risk group, injecting drug users (IDUs), and the...
Saved in:
Main Authors: | Punnee Pitisuttithum, Kachit Choopanya, Supachai Rerk-Ngnam |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/28707 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Prophylactic HIV vaccine: vaccine regimens in clinical trials and potential challenges
by: Punnee Pitisuttithum, et al.
Published: (2020) -
HIV vaccine research in Thailand: Lessons learned
by: Punnee Pitisuttithum
Published: (2018) -
The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection
by: Punnee Pitisuttithum, et al.
Published: (2018) -
Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection
by: Sarah Auclair, et al.
Published: (2019) -
9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV
by: Punnee Pitisuttithum, et al.
Published: (2018)